Biobeat

Biobeat is revolutionizing hypertension diagnosis and management with FDA-cleared cuffless ambulatory blood pressure monitoring. Its wireless, non-invasive medical-grade chest patch measures 24-hour blood pressure without the stress and inconvenience of traditional cuff methods, giving physicians continuous, accurate data for clinical decisions. The company uses a proprietary patented PPG sensor and a comprehensive monitoring platform so clinicians can track vital signs, reduce misdiagnosis, and support optimal treatment. Biobeat holds regulatory approvals in the United States, Europe, and other markets.